바이러스간염의 예방과 예방접종

키워드

참고문헌 (67)

1. 강형민, "단일 병원에서 경험한 최근 급성 바이러스간염의 원인 및 임상 양상", Clinical and Molecular Hepatology, 13(4), pp.495~502 (2007), 대한간학회
2. 정숙향, "국내 A형간염의 현황과 백신 적응증", 대한소화기학회지, 51(6), pp.331~337 (2008), 대한소화기학회
3. "Osong: Korea Centers for Disease Control and Prevention" (2011)[URL]
4. 김진욱, "Hepatitis A in Korea: Epidemiological shift and call for vaccine strategy", INTERVIROLOGY, 51, pp.70~74 (2008), KARGER
5. 이안나, "최근 4년 동안 전국의료기관에서 의뢰된 A형 간염바이러스 혈청 표지자 검사 결과에 대한 역학 분석", Annals of Laboratory Medicine, 29(6), pp.563~569 (2009), 대한진단검사의학회
6. Fiore AE, "Advisory Committee on Immunization Practices (ACIP). Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)", MMWR Recomm Rep, 55(RR-7), pp.1~23 (2006)
7. Rezende G, "Viral and clinical factors associated with the fulminant course of hepatitis A infection", Hepatology, 38, pp.613~618 (2003)
8. McCaustland KA, "Survival of hepatitis A virus in feces after drying and storage for 1 month", J Clin Microbiol, 16, pp.957~958 (1982)
9. Craig AS, "Prevention of hepatitis A with the hepatitis A vaccine", N Engl J Med, 350, pp.476~481 (2004)
10. Van Damme P, "Single dose inactivated hepatitis A vaccine: rationale and clinical assessment of the safety and immunogenicity", J Med Virol, 44, pp.435~441 (1994)
11. Victor J, "Hepatitis A vaccine: a new convenient single-dose schedule with booster when long-term immunization is warranted", Vaccine, 12, pp.1327~1329 (1994)
12. Van Damme P, "Hepatitis A booster vaccination: is there a need?", Lancet, 362, pp.1065~1071 (2003)
13. Rein DB, "Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States", Pediatrics, 119, pp.12~21 (2007)
14. 강진한, "2007년 대한감염학회 권장 성인 예방접종 권장안", Infection and Chemotherapy, 40(1), pp.1~13 (2008), 대한감염학회
15. Keeffe EB, "Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases", Trans Am Clin Climatol Assoc, 117, pp.227~237 (2006)
16. Vento S, "Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C", N Engl J Med, 338, pp.286~290 (1998)
17. Keeffe EB., "Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?", Am J Gastroenterol, 90, pp.201~205 (1995)
18. Victor JC, "Hepatitis A vaccine versus immune globulin for postexposure prophylaxis", N Engl J Med, 357, pp.1685~1694 (2007)
19. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)., "Update: prevention of hepatitis A after exposure to hepatitis A virus and in international travelers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP)", MMWR Morb Mortal Wkly Rep, 56, pp.1080~1084 (2007)
20. Chae HB, "Current status of liver diseases in Korea: hepatitis B", Korean J Hepatol, 15(Suppl 6), pp.13~24 (2009)
21. Jeong S, "Changes of hepatitis B surface antigen seroprevalence in Korea, 1998-2005", Korean J Epidemiol, 30, pp.119~127 (2005)
22. Lok AS, "Chronic hepatitis B", Hepatology, 45, pp.507~539 (2007)
23. 이경인, "최근 10년간 대구ㆍ경북 지역 성인에서 바이러스성 간염 표지자 양성률의 변화양상", 대한소화기학회지, 58(2), pp.82~87 (2011), 대한소화기학회
24. Oh MK, "Seroprevalence of hepatitis B virus markers among adult in a Youngdong area of Kwangwon Province", J Korean Acad Fam Med, 21, pp.91~99 (2000)
25. Kim CY., "Prevention of viral hepatitis, type B, by vaccination with purified hepatitis B surface antigen", J Korean Med Sci, 22, pp.1013~1025 (1976)
26. Mast EE, "A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults", MMWR Recomm Rep, 55, pp.1~33 (2006)
27. Mast EE, "A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents", MMWR Recomm Rep, 54, pp.1~31 (2005)
28. Beasley RP, "Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine", Lancet, 2, pp.1099~1102 (1983)
29. Ngui SL, "Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors", Clin Infect Dis, 27, pp.100~106 (1998)
30. Song YM, "Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus", Eur J Pediatr, 166, pp.813~818 (2007)
31. Wiseman E, "Perinatal transmission of hepatitis B virus: an Australian experience", Med J Aust, 190, pp.489~492 (2009)
32. Del Canho R, "Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity", Vaccine, 15, pp.1624~1630 (1997)
33. Xu WM, "Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study", J Viral Hepat, 16, pp.94~103 (2009)
34. Shi Z, "Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis", Obstet Gynecol, 116, pp.147~159 (2010)
35. Pan C, "A prospective open-label study to evaluate the efficacy, safety and tolerability of telbivudine (LdT) in HBeAg+ chronic hepatitis B (CHB) pregnant women", Hepatology, 52(Suppl 1), pp.500~ (2010)
36. Beasley RP, "Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B", Lancet, 2, pp.740~741 (1975)
37. Hill JB, "Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers", Obstet Gynecol, 99, pp.1049~1052 (2002)
38. Nordenfelt E, "HBsAg positive adopted children as a cause of intrafamilial spread of hepatitis B", Scand J Infect Dis, 10, pp.161~163 (1978)
39. Steinberg SC, "The risk of hepatitis transmission to family contacts of leukemia patients", J Pediatr, 87, pp.753~756 (1975)
40. Harpaz R, "Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control", N Engl J Med, 334, pp.549~554 (1996)
41. Buster EH, "Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions", Antiviral Res, 60, pp.79~85 (2003)
42. Alter HJ, "Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure", N Engl J Med, 295, pp.909~913 (1976)
43. Grady GF, "Eastern equine encephalitis in Massachusetts, 1957-1976: a prospective study centered upon analyses of mosquitoes", Am J Epidemiol, 107, pp.170~178 (1978)
44. Seeff LB, "Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin: final report of the Veterans Administration Cooperative Study", Ann Intern Med, 88, pp.285~293 (1978)
45. "Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures", MMWR Recomm Rep, 40(RR-8), pp.1~9 (1991)
46. Gunson RN, "Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients", J Clin Virol, 27, pp.213~230 (2003)
47. Kenny-Walsh E., "Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin: Irish Hepatology Research Group", N Engl J Med, 340, pp.1228~1233 (1999)
48. Rodger AJ, "Assessment of long-term outcomes of communityacquired hepatitis C infection in a cohort with sera stored from 1971 to 1975", Hepatology, 32, pp.582~587 (2000)
49. Thomas DL, "The natural history of hepatitis C virus infection: host, viral, and environmental factors", JAMA, 284, pp.450~456 (2000)
50. Villano SA, "Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection", Hepatology, 29, pp.908~914 (1999)
51. Mitsui T, "Hepatitis C virus infection in medical personnel after needlestick accident", Hepatology, 16, pp.1109~1114 (1992)
52. Chung H, "Risk of HCV transmission after needlestick injury, and the efficacy of short-duration interferon administration to prevent HCV transmission to medical personnel", J Gastroenterol, 38, pp.877~879 (2003)
53. De Carli G, "Studio Italiano Rischio Occupazionale da HIV Group. Risk of hepatitis C virus transmission following percutaneous exposure in healthcare workers", Infection, 31(Suppl 2), pp.22~27 (2003)
54. 이호준, "제주 지역 만성 C형간질환 환자의 유전자형의 분포", Clinical and Molecular Hepatology, 14(1), pp.28~35 (2008), 대한간학회
55. Thomas DL, "Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships", J Infect Dis, 171, pp.768~775 (1995)
56. Vandelli C, "Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study", Am J Gastroenterol, 99, pp.855~859 (2004)
57. Chen CY, "Age is one of the risk factors in developing gallstone disease in Taiwan", Age Ageing, 27, pp.437~441 (1998)
58. Roberts EA, "Maternal-infant transmission of hepatitis C virus infection", Hepatology, 36(5 Suppl 1), pp.106~113 (2002)
59. Mast EE, "Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy", J Infect Dis, 192, pp.1880~1889 (2005)
60. Lin HH, "Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers", J Pediatr, 126, pp.589~591 (1995)
61. "Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease: Centers for Disease Control and Prevention", MMWR Recomm Rep, 47(RR-19), pp.1~39 (1998)
62. Maheshwari A, "Acute hepatitis C", Lancet, 372, pp.321~332 (2008)
63. 김남진, "급성 E형 간염 1예", Clinical and Molecular Hepatology, 8(2002), pp.312~316 (2002), 대한간학회
64. Park HK, "The seroprevalence of hepatitis E virus (HEV) infection in a Korean population: comparison of two commercial anti-HEV assays", Korean J Hepatol, 17(Suppl 3), pp.54~ (2011)
65. Shrestha MP, "Safety and efficacy of a recombinant hepatitis E vaccine", N Engl J Med, 356, pp.895~903 (2007)
66. Zhu FC, "Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial", Lancet, 376, pp.895~902 (2010)
67. U.S. Public Health Service, "Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis", MMWR Recomm Rep, 50(RR-11), pp.1~52 (2001)

관련 논문AI추천